Clinical Trial Update: Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing stereotactic radiology versus chemotherapy for recurrent or progressive glioblastoma after second-line chemotherapy has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Henry Ford Health System | Conditions: Recurrent or Progressive Glioblastoma | Phase 3 | Status: COMPLETED | Results posted: 2023-07-17